MicroRNA-302a sensitizes testicular embryonal carcinoma cells to cisplatin-induced cell death

Journal of Cellular Physiology

Volumn 228, Issue 12, 2013, Pages 2294-2304

  Liu, Lin ^a   Lian, Jie ^a   Zhang, Huijuan ^a   Tian, Hui ^a   Liang, Meng ^a   Yin, Mianmian ^a   Sun, Fei ^a  

^a UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; MICRORNA; OCTAMER TRANSCRIPTION FACTOR 4; PROTEIN P53; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CARCINOMA CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL DEATH; DOWN REGULATION; DRUG CYTOTOXICITY; GENE SILENCING; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSITIZATION; TESTIS CARCINOMA; UPREGULATION;

APOPTOSIS; CARCINOMA, EMBRYONAL; CELL CYCLE CHECKPOINTS; CELL DEATH; CELL DIVISION; CELL LINE, TUMOR; CISPLATIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; DOWN-REGULATION; G2 PHASE; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICRORNAS; OCTAMER TRANSCRIPTION FACTOR-3; SOXB1 TRANSCRIPTION FACTORS; TESTICULAR NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

EID: 84883040584     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24394     Document Type: Article

References (63)

1. Amantana A, London CA, Iversen PL, Devi GR. 2004. X-linked inhibitor of apoptosis protein inhibition induces apoptosis and enhances chemotherapy sensitivity in human prostate cancer cells. Mol Cancer Ther 3:699-707.
2. Ambros V. 2004. The functions of animal microRNAs. Nature 431:350-355.
3. Andrews PW. 1984. Retinoic acid induces neuronal differentiation of a cloned human embryonal carcinoma cell line in vitro. Dev Biol 103:285-293.
4. Barroso-delJesus A, Romero-Lopez C, Lucena-Aguilar G, Melen GJ, Sanchez L, Ligero G, Berzal-Herranz A, Menendez P. 2008. Embryonic stem cell-specific miR 302-367 cluster: Human gene structure and functional characterization of its core promoter. Mol Cell Biol 28:6609-6619.
5. Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J. 2000. Cell cycle regulators in testicular cancer: Loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumors. Int J Cancer 85:370-375.
6. Beyer J, Kingreen D, Krause M, Schleicher J, Schwaner I, Schwella N, Huhn D, Siegert W. 1997. Long-term survival of patients with recurrent or refractory germ cell tumors after high dose chemotherapy. Cancer 79:161-168.
7. Boehm M, Slack F. 2005. A developmental timing microRNA and its target regulate life span in C. elegans. Science 310:1954-1957.
8. Borgdorff V, Lleonart ME, Bishop CL, Fessart D, Bergin AH, Overhoff MG, Beach DH. 2010. Multiple microRNAs rescue from Ras-induced senescence by inhibiting p21(Waf1/Cip1). Oncogene 29:2262-2271.
9. Bourguignon LY, Wong G, Earle C, Chen L. 2012. Hyaluronan-CD44v3 interaction with Oct4/Sox2/Nanog promotes miR-302 expression leading to self-renewal, clonal formation and cisplatin resistance in cancer stem cells from head and neck squamous cell carcinoma. J Biol Chem 287:32800-32824.
10. Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G. 1997. Lack of correlation between cisplatin-induced apoptosis, p53 status and expression of Bcl-2 family proteins in testicular germ cell tumor cell lines. Int J Cancer 73:592-599.
11. Burger H, Nooter K, Boersma AW, Kortland CJ, Stoter G. 1998. Expression of p53, Bcl-2 and Bax in cisplatin-induced apoptosis in testicular germ cell tumor cell lines. Br J Cancer 77:1562-1567.
12. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y, Archer TK. 2008. Oct4/Sox2-regulated miR-302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 28:6426-6438.
13. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De Jong J, Lopez-Beltran A, Montironi R, Looijenga LH. 2007. OC T4: Biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211:1-9.
14. Chresta CM, Masters JR, Hickman JA. 1996. Hypersensitivity of human testicular tumors to etoposide-induced apoptosis is associated with functional p53 and a high Bax:Bcl-2 ratio. Cancer Res 56:1834-1841.
15. Croce CM. 2009. Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet 10:704-714.
16. di Pietro A, Vries EG, Gietema JA, Spierings DC, de Jong S. 2005. Testicular germ cell tumors: The paradigm of chemo-sensitive solid tumors. Int J Biochem Cell Biol 37:2437-2456.
17. El-Helw L, Coleman RE. 2005. Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumors. Cancer Treat Rev 31:197-209.
18. Elmore S. 2007. Apoptosis: A review of programmed cell death. Toxicol Pathol 35:495-516.
19. Frank NY, Schatton T, Frank MH. 2010. The therapeutic promise of the cancer stem cell concept. J Clin Invest 120:41-50.
20. Gutekunst M, Oren M, Weilbacher A, Dengler MA, Markwardt C, Thomale J, Aulitzky WE, van der Kuip H. 2011. p53 hypersensitivity is the predominant mechanism of the unique responsiveness of testicular germ cell tumor (TGCT) cells to cisplatin. PLoS ONE 6:e9198.
21. Honecker F, Wermann H, Mayer F, Gillis AJ, Stoop H, van Gurp RJ, Oechsle K, Steyerberg E, Hartmann JT, Dinjens WN, Oosterhuis JW, Bokemeyer C, Looijenga LH. 2009. Microsatellite instability, mismatch repair deficiency, and BRAF mutation in treatment-resistant germ cell tumors. J Clin Oncol 27:2129-2136.
22. Horwich A, Shipley J, Huddart R. 2006. Testicular germ-cell cancer. Lancet 367:754-765.
23. Ishioka J, Fujii Y, Kageyama Y, Fukuda H, Higashi Y, Kihara K. 2008. Cardiovascular events in survivors of high-dose chemotherapy for germ cell tumors. Int J Urol 15:642-645.
24. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, Kobayashi SV, Lim L, Burchard J, Jackson AL, Linsley PS, Cleary MA. 2008. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol 28:2167-2174.
25. Jones TD, Ulbright TM, Eble JN, Cheng L. 2004. OC T4: A sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 10:8544-8547.
26. Kanatsu-Shinohara M, Inoue K, Lee J, Yoshimoto M, Ogonuki N, Miki H, Baba S, Kato T, Kazuki Y, Toyokuni S, Toyoshima M, Niwa O, Oshimura M, Heike T, Nakahata T, Ishino F, Ogura A, Shinohara T. 2004. Generation of pluripotent stem cells from neonatal mouse testis. Cell 119:1001-1012.
27. Kerley-Hamilton JS, Pike AM, Li N, DiRenzo J, Spinella MJ. 2005. A p53-dominant transcriptional response to cisplatin in testicular germ cell tumor-derived human embryonal carcinoma. Oncogene 24:6090-6100.
28. Kloosterman WP, Plasterk RH. 2006. The diverse functions of microRNAs in animal development and disease. Dev Cell 11:441-450.
29. Kuijk EW, van Mil A, Brinkhof B, Penning LC, Colenbrander B, Roelen BA. 2010. PTEN and TRP53 independently suppress Nanog expression in spermatogonial stem cells. Stem Cells Dev 19:979-988.
30. Kuo MT, Chen HH, Song IS, Savaraj N, Ishikawa T. 2007. The roles of copper transporters in cisplatin resistance. Cancer Metastasis Rev 26:71-83.
31. Lian J, Tian H, Liu L, Zhang XS, Li WQ, Deng YM, Yao GD, Yin MM, Sun F. 2010. Down-regulation of microRNA-383 is associated with male infertility and promotes testicular embryonal carcinoma cell proliferation by targeting IRF1. Cell Death Dis 1:e94.
32. Liang Z, Wu H, Xia J, Li Y, Zhang Y, Huang K, Wagar N, Yoon Y, Cho HT, Scala S, Shim H. 2010. Involvement of miR-326 in chemotherapy resistance of breast cancer through modulating expression of multidrug resistance-associated protein 1. Biochem Pharmacol 79:817-824.
33. Liang N, Xu Y, Yin Y, Yao G, Tian H, Wang G, Lian J, Wang Y, Sun F. 2011. Steroidogenic factor-1 is required for TGF-beta3-mediated 17beta-estradiol synthesis in mouse ovarian granulosa cells. Endocrinology 152:3213-3225.
34. Lin T, Chao C, Saito S, Mazur SJ, Murphy ME, Appella E, Xu Y. 2005. p53 induces differentiation of mouse embryonic stem cells by suppressing Nanog expression. Nat Cell Biol 7:165-171.
35. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT, Ying SY. 2008. Mir-302 reprograms human skin cancer cells into a pluripotent ES-cell-like state. RNA 14:2115-2124.
36. Lin SL, Chang DC, Ying SY, Leu D, Wu DT. 2010. MicroRNA miR-302 inhibits the tumorigenicity of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell cycle pathways. Cancer Res 70:9473-9482.
37. Lin SL, Chang DC, Lin CH, Ying SY, Leu D, Wu DT. 2011. Regulation of somatic cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 39:1054-1065.
38. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE, van Zoelen EJ, Weber RF, Wolffenbuttel KP, van Dekken H, Honecker F, Bokemeyer C, Perlman EJ, Schneider DT, Kononen J, Sauter G, Oosterhuis JW. 2003. POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63:2244-2250.
39. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S, Guenther MG, Johnston WK, Wernig M, Newman J, Calabrese JM, Dennis LM, Volkert TL, Gupta S, Love J, Hannett N, Sharp PA, Bartel DP, Jaenisch R, Young RA. 2008. Connecting microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells. Cell 134:521-533.
40. Masters JR, Osborne EJ, Walker MC, Parris CN. 1993. Hypersensitivity of human testis-tumor cell lines to chemotherapeutic drugs. Int J Cancer 53:340-346.
41. Mueller S, Schittenhelm M, Honecker F, Malenke E, Lauber K, Wesselborg S, Hartmann JT, Bokemeyer C, Mayer F. 2006a. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro. Int J Oncol 29:471-479.
42. Mueller T, Mueller LP, Luetzkendorf J, Voigt W, Simon H, Schmoll HJ. 2006b. Loss of Oct-3/4 expression in embryonal carcinoma cells is associated with induction of cisplatin resistance. Tumor Biol 27:71-83.
43. Murray MJ, Halsall DJ, Hook CE, Williams DM, Nicholson JC, Coleman N. 2011. Identification of microRNAs From the miR-371~373 and miR-302 clusters as potential serum biomarkers of malignant germ cell tumors. Am J Clin Pathol 135:119-125.
44. Palmer RD, Murray MJ, Saini HK, van Dongen S, Abreu-Goodger C, Muralidhar B, Pett MR, Thornton CM, Nicholson JC, Enright AJ, Coleman N. 2010. Malignant germ cell tumors display common microRNA profiles resulting in global changes in expression of messenger RNA targets. Cancer Res 70:2911-2923.
45. Park SM, Shell S, Radjabi AR, Schickel R, Feig C, Boyerinas B, Dinulescu DM, Lengyel E, Peter ME. 2007. Let-7 prevents early cancer progression by suppressing expression of the embryonic gene HMGA2. Cell Cycle 6:2585-2590.
46. Pliarchopoulou K, Pectasides D. 2010. Late complications of chemotherapy in testicular cancer. Cancer Treat Rev 36:262-267.
47. Qin H, Yu T, Qing T, Liu Y, Zhao Y, Cai J, Li J, Song Z, Qu X, Zhou P, Wu J, Ding M, Deng H. 2007. Regulation of apoptosis and differentiation by p53 in human embryonic stem cells. J Biol Chem 282:5842-5852.
48. Rosa A, Brivanlou AH. 2011. A regulatory circuitry comprised of miR-302 and the transcription factors OCT4 and NR2F2 regulates human embryonic stem cell differentiation. EMBO J 30:237-248.
49. Sark MW, Timmer-Bosscha H, Meijer C, Uges DR, Sluiter WJ, Peters WH, Mulder NH, de Vries EG. 1995. Cellular basis for differential sensitivity to cisplatin in human germ cell tumor and colon carcinoma cell lines. Br J Cancer 71:684-690.
50. Scheel AH, Beyer U, Agami R, Dobbelstein M. 2009. Immunofluorescence-based screening identifies germ cell associated microRNA 302 as an antagonist to p63 expression. Cell Cycle 8:1426-1432.
51. Schweyer S, Soruri A, Meschter O, Heintze A, Zschunke F, Miosge N, Thelen P, Schlott T, Radzun HJ, Fayyazi A. 2004. Cisplatin-induced apoptosis in human malignant testicular germ cell lines depends on MEK/ERK activation. Br J Cancer 91:589-598.
52. Si ML, Zhu S, Wu H, Lu Z, Wu F, Mo YY. 2007. miR-21-mediated tumor growth. Oncogene 26:2799-2803.
53. Spierings DC, de Vries EG, Vellenga E, de Jong S. 2003. Loss of drug-induced activation of the CD95 apoptotic pathway in a cisplatin-resistant testicular germ cell tumor cell line. Cell Death Differ 10:808-822.
54. Spierings DC, de Vries EG, Stel AJ, te Rietstap N, Vellenga E, de Jong S. 2004. Low p21Waf1/Cip1 protein level sensitizes testicular germ cell tumor cells to Fas-mediated apoptosis. Oncogene 23:4862-4872.
55. Stadler B, Ivanovska I, Mehta K, Song S, Nelson A, Tan Y, Mathieu J, Darby C, Blau CA, Ware C, Peters G, Miller DG, Shen L, Cleary MA, Ruohola-Baker H. 2010. Characterization of microRNAs involved in embryonic stem cell states. Stem Cells Dev 19:935-950.
56. Takeshita F, Patrawala L, Osaki M, Takahashi RU, Yamamoto Y, Kosaka N, Kawamata M, Kelnar K, Bader AG, Brown D, Ochiya T. 2010. Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via down-regulation of multiple cell-cycle genes. Mol Ther 18:181-187.
57. Teshima S, Shimosato Y, Hirohashi S, Tome Y, Hayashi I, Kanazawa H, Kakizoe T. 1988. Four new human germ cell tumor cell lines. Lab Invest 59:328-336.
58. Wu S, Huang S, Ding J, Zhao Y, Liang L, Liu T, Zhan R, He X. 2010. Multiple microRNAs modulate p21Cip1/Waf1 expression by directly targeting its 3′ untranslated region. Oncogene 29:2302-2308.
59. Yadav S, Pandey A, Shukla A, Talwelkar SS, Kumar A, Pant AB, Parmar D. 2011. miR-497 and miR-302b regulate ethanol-induced neuronal cell death through BCL2 protein and cyclin D2. J Biol Chem 286:37347-37357.
60. Yao G, Yin M, Lian J, Tian H, Liu L, Li X, Sun F. 2010. MicroRNA-224 is involved in transforming growth factor-beta-mediated mouse granulosa cell proliferation and granulosa cell function by targeting Smad4. Mol Endocrinol 24:540-551.
61. Yin M, Lu M, Yao G, Tian H, Lian J, Liu L, Liang M, Wang Y, Sun F. 2012. Transactivation of microRNA-383 by steroidogenic factor-1 promotes estradiol release from mouse ovarian granulosa cells by targeting RBMS1. Mol Endocrinol 26:1129-1143.
62. Zhang K, Chew M, Yang EB, Wong KP, Mack P. 2001. Modulation of cisplatin cytotoxicity and cisplatin-induced DNA cross-links in HepG2 cells by regulation of glutathione-related mechanisms. Mol Pharmacol 59:837-843.
63. Zhao JJ, Lin J, Yang H, Kong W, He L, Ma X, Coppola D, Cheng JQ. 2008. MicroRNA-221/222 negatively regulates estrogen receptor alpha and is associated with tamoxifen resistance in breast cancer. J Biol Chem 283:31079-31086.